关注
Nasir Nisar
Nasir Nisar
Department of pharmaceutical Sciences, University of Kashmir.
在 kashmiruniversity.net 的电子邮件经过验证
标题
引用次数
引用次数
年份
Flavonoids as promising molecules in the cancer therapy: An insight
SA Mir, A Dar, L Hamid, N Nisar, JA Malik, T Ali, GN Bader
Current Research in Pharmacology and Drug Discovery, 100167, 2023
92023
Mu-opioid receptor antagonists and their role in treatment of chronic constipation
O Kareem, N Nisar, N Tabassum
Journal of Critical Reviews 4 (5), 2017
62017
Proteomics approaches in the identification of cancer biomarkers and drug discovery
N Nisar, SA Mir, O Kareem, FH Pottoo
Proteomics, 77-120, 2023
42023
COMPARISON OF SURVIVAL AND ADVERSE EFFECT PROFILE IN PATIENTS WITH ESOPHAGEAL CANCER TREATED WITH THE COMBINATION OF CARBOPLATIN AND PACLITAXEL VS. 5-FLOUROURACIL AND CISPLATIN
N NISAR, MM LONE, N TABASSUM
World Cancer Research Journal, 2022
22022
Current Research in Pharmacology and Drug Discovery
SA Mir, A Dar, L Hamid, N Nisar, JA Malik, T Ali, GN Bader
Current Research in Pharmacology and Drug Discovery 6, 100167, 2024
2024
系统目前无法执行此操作，请稍后再试。
文章 1–5
共建清朗的网络空间,如遇有害信息,请举报。
本站数据皆整合自互联网公开资源索引,方便科研学术方面查询,并不存储相关数据资源;如对此有异议,请联系我们解决.
© 2023 学术资源搜索   @联系我们 | 申请短期会员 | 数据源提交